Question 1

What is the catalog number for Histone H2Ax (H2AX) Antibody?

Accepted Answer

The catalog number for Histone H2Ax (H2AX) Antibody is abx422657.

Question 2

What sizes are available for Histone H2Ax (H2AX) Antibody?

Accepted Answer

Histone H2Ax (H2AX) Antibody is available in the following size(s): 100 µg, 1 mg.

Question 3

How many pack sizes does Histone H2Ax (H2AX) Antibody come in?

Accepted Answer

Histone H2Ax (H2AX) Antibody is available in 2 different pack sizes.

Question 4

Is Histone H2Ax (H2AX) Antibody in stock?

Accepted Answer

Histone H2Ax (H2AX) Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Histone H2Ax (H2AX) Antibody

Product Specifications

Clonality

Conjugation

Applications

Notes

Host or Source

Available Sizes

Frequently Asked Questions

Explore Other Products

CALCOCO2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI6E8]

Human KIAA2026 activation kit by CRISPRa

Di-tert-butyltin Dichloride

Slc38a6 Mouse Gene Knockout Kit (CRISPR)

(11beta,20R)-11,20-Dihydroxy-3-oxopregn-4-en-21-oic acid

TMEM229B Human Gene Knockout Kit (CRISPR)